| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/25/2010 | US20100048674 Role of miRNA in T cell leukemia |
| 02/25/2010 | US20100048650 Two pore channels as a therapeutic target to protect against myocardial ischemia and as an adjuvant in cardiac surgery |
| 02/25/2010 | US20100048567 Inhibitors of syk and JAK protein kinases |
| 02/25/2010 | US20100048548 Imino-oxazolidines and use thereof |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | US20100048524 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| 02/25/2010 | US20100048487 Novel cell penetrating peptide |
| 02/25/2010 | US20100048480 Production of anti-microbial peptides |
| 02/25/2010 | US20100048477 Method for prevention of platelet aggregation employing an rgd-enriched gelatine-like proteins |
| 02/25/2010 | US20100048472 Albumin Fusion Proteins |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048426 Enhanced Expression from the Pm Promoter |
| 02/25/2010 | US20100048411 Substrate for the growth of cultured cells in three dimensions |
| 02/25/2010 | US20100048405 Development of herbicide-resistant grass species |
| 02/25/2010 | US20100047912 Apparatus, method and system for creating, collecting and indexing seed portions from individual seed |
| 02/25/2010 | US20100047911 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 02/25/2010 | US20100047910 Supramolecular complexes as photoactivated dna cleavage agents |
| 02/25/2010 | US20100047909 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof |
| 02/25/2010 | US20100047908 Monocyte-derived stem cells |
| 02/25/2010 | US20100047907 Methods of transporting epithelial cell monolayers |
| 02/25/2010 | US20100047906 Germ lineage derived feeder cells and methods thereof |
| 02/25/2010 | US20100047905 Simulated blood components and methods |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047895 Methods for purification of bacterial cells and cell components |
| 02/25/2010 | US20100047894 Use of Matrix Metalloproteinases, Mutated and Not Mutated, for the Preparation of Pharmaceutical Compositions, and Mutated Metalloproteinases with Increased Stability |
| 02/25/2010 | US20100047892 Method for modifying cells |
| 02/25/2010 | US20100047877 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 02/25/2010 | US20100047867 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 02/25/2010 | US20100047865 Vector for expressing nc protein of hiv and method for producing nc protein using the same |
| 02/25/2010 | US20100047854 Method for detection of human precursor t cell and precursor b cell |
| 02/25/2010 | US20100047853 Ex Vivo Culture, Proliferation and Expansion of Intestinal Epithelium |
| 02/25/2010 | US20100047846 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/25/2010 | US20100047845 Method of reducing curvature in a meniscus of liquid medium |
| 02/25/2010 | US20100047843 Compositions and methods for enhancing the growth of mouse embryonic stem cells |
| 02/25/2010 | US20100047827 Novel specific cell binders |
| 02/25/2010 | US20100047826 Cell Into Which Protein, Which Can Serve as Polymerization Nucleus of Protein Polymer, or Polymer Thereof Is Introduced, and Method for Production of The Cell |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047805 Methods and compositions for targeted single-stranded cleavage and targeted integration |
| 02/25/2010 | US20100047776 Cell-based screening assays for compounds that regulate the expresion of a tumor marker dj-1 |
| 02/25/2010 | US20100047769 having controlling effects on growth and differentiation of undifferentiated cells; can affect stem cells to trigger the growth arrest signal; inhibits a SELF promoter activity |
| 02/25/2010 | US20100047761 Capillary transport |
| 02/25/2010 | US20100047551 Composite materials comprising supported porous gels |
| 02/25/2010 | US20100047392 Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them |
| 02/25/2010 | US20100047368 Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
| 02/25/2010 | US20100047316 Repair of cartilage tissue using a matrix gel containing chondrocytes |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047288 Hybrid cells for treating cancer patients |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047272 Therapeutic vaccine comprising mycobacterial heat shock protein 70 |
| 02/25/2010 | US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047257 Antagonist antibody for the treatment of cancer |
| 02/25/2010 | US20100047255 Novel activation and transfer cascade for ubiquitin |
| 02/25/2010 | US20100047253 Fully human monoclonal antibodies to il-13 |
| 02/25/2010 | US20100047252 Antibody with protein a selectivity |
| 02/25/2010 | US20100047246 Methods and Compositions for Treating Vascular Disease |
| 02/25/2010 | US20100047245 Complementary determining regions (CDR); interleukins (IL-12) |
| 02/25/2010 | US20100047243 Novel antibodies against igf-ir |
| 02/25/2010 | US20100047238 Humanized antibodies against |
| 02/25/2010 | US20100047237 Prevention of aggregation of immunoglobulin light or heavy chains |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047230 Anti her2/neu antibody |
| 02/25/2010 | US20100047227 Novel anticancer cathepsin formulations and anticancer agent for use in combined anticancer therapy |
| 02/25/2010 | US20100047226 Compositions and methods for inhibiting tumor cell growth |
| 02/25/2010 | US20100047224 Biosilica-Adhesive Protein Nanocomposite Materials: Synthesis and Application in Dentistry |
| 02/25/2010 | US20100047220 Substances |
| 02/25/2010 | US20100047218 Reversible immortalization |
| 02/25/2010 | US20100047217 Differentiated anucleated cells and method for preparing the same |
| 02/25/2010 | US20100047216 Compositions of late passage mesenchymal stem cells (mscs) |
| 02/25/2010 | US20100047214 Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations |
| 02/25/2010 | US20100047213 Cell composition and methods of making the same |
| 02/25/2010 | US20100047212 Use of the pedf factor to induce cell regeneration |
| 02/25/2010 | US20100047211 Method of growth of mesenchymal cells under non-adherent conditions for clinical applications |
| 02/25/2010 | US20100047170 Peptide Prodrugs |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | US20100047166 Antibodies and related molecules that bind to 58p1d12 proteins |
| 02/25/2010 | US20100044316 Composite materials comprising supported porous gels |
| 02/25/2010 | DE102008036060A1 Zellbasiertes Verfahren und Mittel zum Knochenaufbau Cell-based method and means for bone formation |
| 02/25/2010 | CA2769282A1 Cell culture method |
| 02/25/2010 | CA2756738A1 Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes |
| 02/25/2010 | CA2734578A1 Antibodies to ccr2 |
| 02/25/2010 | CA2734515A1 Inhbb epitope peptides and vaccines containing the same |
| 02/25/2010 | CA2734446A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 02/25/2010 | CA2734428A1 Susceptibility to hsp90-inhibitors |
| 02/25/2010 | CA2734237A1 Treatment of stroke using isolated placental cells |
| 02/25/2010 | CA2734236A1 Improved cell composition and methods of making the same |
| 02/25/2010 | CA2734210A1 Monoclonal antibody stro-4 |
| 02/25/2010 | CA2733505A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/24/2010 | EP2157183A1 Plant polynucleotides encoding prenyl proteases |
| 02/24/2010 | EP2157179A1 Glycerol-3-phosphate acyltransferase (gpat) homologs and use thereof |
| 02/24/2010 | EP2157173A1 An avian embryo particulate biomass for the production of virus antigens |
| 02/24/2010 | EP2157172A2 Plants having improved growth characteristics and methods for making the same |
| 02/24/2010 | EP2157171A1 Method for locally modifying the elasticity of a substrate designed for the growth of cells thereon |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2156879A2 Methods, compositions and automated systems for separating rare cells from fluid samples |
| 02/24/2010 | EP2155880A1 Modifying glycoprotein production in plants |
| 02/24/2010 | EP2155875A2 Nucleic acids and libraries for use in functional analysis of regulatory rnas such as micrornas (mirnas) |
| 02/24/2010 | EP2155872A1 Tem8 peptides and vaccines comprising the same |